Life Sciences Conferences

The Burrill Personalized Medicine Meeting

Agenda

---

PRELIMINARY DRAFT AGENDA


Monday, November 10, 2008

7:30 – 8:30 a.m.
Breakfast & Registration

8:30 – 8:45 a.m.
Welcome & Introduction
- Caroline A. Kovac, PhD, Managing Director, Burrill & Company

8:45 – 10:00 a.m.
Industry Update:
State of the Personalized, Predictive and Preventative Medicine World
- G. Steven Burrill, CEO, Burrill & Company

10:00 – 10:30 a.m.
Break

10:30 – 11:45 a.m.
Personalized Medicine in the Clinic: Advances in Diagnosis and Treatment of Cancer
Panelists:
- Anna Barker, Deputy Director, National Cancer Institute (invited)
- Franklyn Prendergast, MD, PhD, Director, Center for Individualized Medicine Research, Mayo Clinic (confirmed)
- Randal W. Scott, PhD, Chairman & CEO, Genomic Health (confirmed)
- Jeff Trent, CEO, Translational Genomics Institute (invited)

11:45 a.m. – 1:15 p.m.
‘Conversations with Experts’ Luncheon

1:15 – 2:30 p.m.
Keynote Interview: The FDA and Regulatory Approval

2:30 – 2:45 p.m.
Break

2:45 – 3:30 p.m.
Keynote Speaker: Personalized Medicine After Herceptin
- Susan Desmond-Hellmann, MD, MPH, President, Product Development, Genentech (confirmed)

3:30 – 4:45 p.m.
Personalized Medicine in the Clinic: Beyond Cancer
Panelists:
- Dan Farkas, Director, Center for Molecular Medicine (confirmed)
- Dean Sproles, CEO, Iverson Genetics (confirmed)

4:45 – 5:00 p.m.
Day One Meeting Wrap-Up
- Caroline A. Kovac, PhD, Managing Director, Burrill & Company

5:00 – 6:30 p.m.
Networking Reception



Tuesday, November 11, 2008

7:30 – 8:30 a.m.
Breakfast

8:30 – 9:45 a.m.
Reimbursement, Financing and Business Models in Personalized Medicine
Panelist:
- Matthew Hudes, National Managing Principal, Deloitte Consulting (invited)

9:45 – 10:15 a.m.
Break

10:15 – 11:45 a.m.
Patient-Centric Medicine: PM from the Patient’s Point of View

11:45 a.m. – 1:00 p.m.
Lunch

1:00 – 2:00 p.m.
Keynote Speaker: “Healthcare Reform and the Impact of Personalized, Preventative Medicine”

2:00 – 3:15 p.m.
Personalized Medicine and Public Policy
Panelist:
- Ed Abrahms, CEO, The Personalized Medicine Coalition (confirmed)

3:15 – 3:30 p.m.
Meeting Wrap-Up
- Caroline A. Kovac, PhD, Managing Director, Burrill & Company